Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,773 public trials 497 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen

NCT00623831

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +50 more
Locations: Krankenhaus Nordwest Frankfurt, Germany

View Trial Details

Completed

Study of NY-ESO-1 ISCOMATRIX® in Patients With Measurable Stage III or IV Melanoma

NCT00518206

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Peter MacCallum Cancer Institute East Melbourne, Victoria, Australia

Austin Health (Ludwig Institute Oncology Unit) Heidelberg, Victoria, Australia

View Trial Details

Completed

Study of ADI-PEG 20 in Patients With Advanced Melanoma

NCT00520299

Conditions: Melanoma, Metastatic Melanoma, Neoplasm, +12 more
Locations: NYU Cancer Institute New York, United States

Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Optical Biopsy of Human Skin in Conjunction With Laser Treatment

NCT00540566

Conditions: Adenocarcinoma, Atypical Nevi, Basal Cell Carcinoma, +64 more
Locations: Beckman Laser Institute, Unversity of California Irvine Irvine, California, United States

View Trial Details

Completed

Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy

NCT02357992

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +19 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma

NCT03396952

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +14 more
Locations: University of Califonia, San Francisco San Francisco, California, United States

View Trial Details

Completed

Study of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected Melanoma

NCT00199901

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Sydney Melanoma Unit - Royal Prince Alfred Hospital Camperdown, New South Wales, Australia

Newcastle Melanoma Unit - Newcastle Mater Misericordiae Hospital Newcastle, New South Wales, Australia

Mater Medical Centre, Princess Alexandra Hospital Woolloongabba, Queensland, Australia

Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia

View all 15 locations

View Trial Details

Completed

Safety and Efficacy of AK104, a PD-1/CTLA-4 Bispecific Antibody, in Selected Advanced Solid Tumors

NCT04172454

Conditions: Advanced Solid Tumors, Melanoma, Neoplasms, +10 more
Locations: Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Completed

Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma

NCT00679289

Conditions: Cutaneous Melanoma, Melanoma, Metastatic Melanoma, +11 more
Locations: University of Chicago Hospital Chicago, Illinois, United States

University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)

NCT00142454

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: NYU Cancer Institute New York, United States

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions